HRMY

Harmony Biosciences Holdings, Inc. is a leading commercial-stage pharmaceutical company based in Plymouth Meeting, Pennsylvania, specializing in innovative therapies for rare neurological disorders. With a primary focus on conditions such as narcolepsy, the company is committed to meeting significant unmet medical needs within the neurology sector. Its robust product pipeline, combined with cutting-edge research and development capabilities, underscores Harmony's strategic position in the specialty pharmaceuticals landscape. By concentrating on rare diseases, the company is poised for considerable growth while enhancing patient quality of life, establishing itself as a vital contributor to advancements in healthcare.